The Circadian Hysteresis Hypothesis: Chrono-disruption as a Failure of the 'Decompression' Signal in Protective Proteostasis

The Hypothesis

I’m proposing that neurodegenerative protein aggregation isn't just a stochastic failure of cellular clearance, but rather a circadian hysteresis failure. In this model, the formation of stress granules and insoluble deposits like TDP-43, tau, and $\alpha$-synuclein represents a rhythmic, BMAL1-gated "compression state." This state is designed to sequester reactive proteotropic species during periods of high metabolic flux. Pathological neurodegeneration happens when chronic circadian misalignment—think shift work—dampens the amplitude of the "all-clear" signal, preventing the cell from transitioning out of this emergency sequestration mode. The aggregates "lock" into an irreversible solid phase not because the cell is overwhelmed by trash, but because it’s lost the temporal cue to re-solubilize them.

Mechanistic Reasoning

Evidence from C. elegans suggests that aggregation functions as a regulated protective sequestration mechanism. Cells appear to deliberately concentrate harmful proteins into chaperone-rich deposits to neutralize soluble toxicity [https://pmc.ncbi.nlm.nih.gov/articles/PMC10501630/]. This "compression algorithm" is likely an evolved survival strategy. However, maintaining proteins in a sequestered yet reversible state, such as liquid-liquid phase separation or metastable aggregates, is bioenergetically expensive and requires constant chaperone surveillance [https://www.fightaging.org/archives/2015/05/protein-aggregation-as-a-protective-mechanism/].

I'd argue that the circadian clock is the primary regulator of this metabolic budget. BMAL1 rhythmically gates endolysosomal function and autophagic flux [https://pmc.ncbi.nlm.nih.gov/articles/PMC10194014/]. More specifically, I hypothesize that BMAL1 also regulates the rhythmic expression of nucleocytoplasmic transport (NCT) factors and disaggregases, such as DNAJB1/HSP70 complexes.

In a healthy system:

1. Activity Phase: High metabolic flux leads to protein misfolding; BMAL1 triggers the "compression" of these proteins into protective granules.
2. Rest Phase: BMAL1-driven upregulation of autophagy and disaggregases triggers "decompression" or orderly degradation.

In the shift-worker's brain, where circadian transcript amplitudes are often dampened by about 27% [https://www.pnas.org/doi/10.1073/pnas.1720719115], the "rest phase" signal never reaches the threshold required to mobilize the disaggregation machinery. The cell remains stuck in a permanent "emergency state." This prolonged residence time within sequestered granules facilitates a liquid-to-solid phase transition, eventually resulting in the insoluble, hyper-phosphorylated hallmarks of Alzheimer’s and Parkinson’s [https://www.oaepublish.com/articles/and.2021.10].

Engaging the Critic

Critics of the "protective aggregation" view often point to the obvious correlation between aggregate burden and neuronal death. However, this conflates the process with the failure to terminate the process. If we view aggregates as sandbags against a flood, traditional therapies are essentially trying to dissolve the sandbags while the cell still perceives a rising tide. By restoring BMAL1 amplitude, we don't just "clear trash"; we provide the biological signal that the emergency is over, allowing the cell to naturally re-allocate its resources toward proteostatic fluidity.

Testability and Falsification

We can test this hypothesis through a few specific experimental designs:

• Test: In a BMAL1-deficient astrocyte or neuronal model, provide a transient heat shock to induce stress granules. Measure the re-solubilization kinetics of TDP-43 or G3BP1 compared to wild-type cells.
• Falsification: If restoring BMAL1 amplitude in a model of established aggregation actually increases proteotoxicity—suggesting the aggregates were the only thing keeping the cell alive—the idea that the "lock-in" is the primary driver of decay would be falsified.
• Prediction: I predict that rhythmic administration of a BMAL1 stabilizer like SR9011 will enhance the solubility of the proteome even without an increase in total degradative capacity, simply by lowering the kinetic barrier for disaggregation.